menu
    • menu

    Company profile for Viewpoint Molecular Targeting

    NEW Drugs in Dev.: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Viewpoint Molecular Targeting is a radiopharmaceutical company developing precision oncology therapeutics and complementary diagnostic imaging agents. The Company’s leading alpha-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells utilizing specialized targeting peptides. Viewpoint is also developing complementary diagnostics that utilize the same targeting peptide which prov...
    Viewpoint Molecular Targeting is a radiopharmaceutical company developing precision oncology therapeutics and complementary diagnostic imaging agents. The Company’s leading alpha-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells utilizing specialized targeting peptides. Viewpoint is also developing complementary diagnostics that utilize the same targeting peptide which provide the opportunity to personalize treatment and optimize patient outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Viewpoint Molecular TargetingUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2500 Crosspark Rd Coralville, IA 52241
    Telephone
    Telephone
    1-865-356-1861
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://viewpointmt.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/viewpointmt/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Isoray Completes Merger with Viewpoint Molecular Targeting to Treatment Paradigm
    Isoray Completes Merger with Viewpoint Molecular Targeting to Treatment Paradigm

    06 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230206005219/en

    BUSINESSWIRE
    06 Feb 2023
    Share Share
    Viewpoint Molecular Targeting Announces First Neuroendocrine Tumor Patients
    Viewpoint Molecular Targeting Announces First Neuroendocrine Tumor Patients

    23 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230123005190/en

    BUSINESSWIRE
    23 Jan 2023
    Share Share
    Isoray & Viewpoint Molecular Announce Investor Webcast on October 19, 2022
    Isoray & Viewpoint Molecular Announce Investor Webcast on October 19, 2022

    18 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221017005973/en

    BUSINESSWIRE
    18 Oct 2022
    Share Share
    Viewpoint Molecular Targeting Announces Transformational Merger
    Viewpoint Molecular Targeting Announces Transformational Merger

    29 Sep 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/viewpoint-molecular-targeting-announces-transformational-merger/?s=79

    BIOSPACE
    29 Sep 2022
    Share Share
    Viewpoint Molecular Targeting Announces Publication of Preclinical Data of VMT01
    Viewpoint Molecular Targeting Announces Publication of Preclinical Data of VMT01

    24 Sep 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/viewpoint-molecular-targeting-r-announces-publication-of-preclinical-data-of-vmt01-in-peer-reviewed-journal-cancers-/

    BIOSPACE
    24 Sep 2021
    Share Share
    Viewpoint MolecularTargeting Receives Clearance of IND Application for VMT-a-NET
    Viewpoint MolecularTargeting Receives Clearance of IND Application for VMT-a-NET

    09 Sep 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/viewpoint-molecular-targeting-tm-receives-fda-clearance-of-investigational-new-drug-application-for-phase-1-imaging-study-for-vmt-a-net-for-neuroendocrine-tumors/?s=85

    BIOSPACE
    09 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Contact Viewpoint Molecular Targeting and get a quotation

    Viewpoint Molecular Targeting is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of [203PB]VMT-A-NET SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY AGENT bulk with DMF offered by Viewpoint Molecular Targeting

    Find a price of [212Pb]VMT-A-NET bulk with DMF offered by Viewpoint Molecular Targeting

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search